Physician profile
Brian D Jackson
NPI 1306842356
$873.25
in general payments reported to CMS, 2019-2025
11 companies · $14.70 in 2025
The $14.70 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.57 · 2021: $203 · 2022: $97.96 · 2023: $203 · 2024: $327 · 2025: $14.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $322.04 | 2021-2024 | |
| Convatec INC. | $306.50 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $62.89 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $41.21 | 2019-2022 | |
| Progenacare Global, LLC | $32.63 | 2023 | |
| Triad Life Sciences INC. | $24.83 | 2022 | |
| Solventum Corporation | $20.20 | 2024 | V.A.C. Dermatac, Activ.A.C. |
| Smith+Nephew, INC. | $17.19 | 2024 | Collagenase Santyl, Regranex |
| Abbott Laboratories | $16.52 | 2024 | Eterna |
| Medtronic, INC. | $14.97 | 2024 | Arcpoint |
| Nevro Corp. | $14.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.